Endocrine symptom assessment in women with breast cancer: what a simple “yes” means

Ribi, Karin; Bernhard, Jürg; Rufibach, Kaspar; Thürlimann, Beat; Moos, Roger von; Ruhstaller, Thomas; Glaus, A; Böhme, Christel

doi:10.1007/s00520-007-0258-3

Cited by 11 publications

(12 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…However, as it includes elements of an intangible nature, for example, guilt, hopelessness, and fear, its quantification could be difficult. Subjective aspects, such as fear of medication supply running out, the meaning attributed to side‐effects, beliefs about a medication's effectiveness and beliefs about the impact of medication on health and well‐being (e.g. believing that medication is harmful and addictive), were associated with increased levels of treatment burden …”

Section: Resultsmentioning

confidence: 99%

“…Bernhard et al 13 Switzerland/ Italy n = 249 patients in a trial for the prophylaxis for delayed emesis Quantitative survey and diary cards Ribi et al 16 Switzerland n = 373 women with early or advanced breast cancer Quantitative survey Yoon et al 47 USA n = 1,219 women with breast cancer Quantitative survey Ow 33 Singapore n = 22 parents from 20 families with children with childhood cancer…”

Section: Quantitative Surveymentioning

confidence: 99%

“…Few validated instruments have been developed to assess the experiences of treatment burden on patients. [5][6][7][8][9][10][11][12][13][14][15][16] In some cases however, the concept of treatment burden has been included as one domain within a multidimensional instrument designed to assess health-related quality of life or treatment satisfaction. [5][6][7][8][9][10][11][12]17,18 These measures reflect wide variation in terms of the dimensions of treatment burden and its definition.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Burden of treatment for chronic illness: a concept analysis and review of the literature

Sav

King

Whitty

et al. 2013

Health Expectations

264

View full text Add to dashboard Cite

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Quantitative Surveymentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Burden of treatment for chronic illness: a concept analysis and review of the literature

Sav

King

Whitty

et al. 2013

Health Expectations

264

View full text Add to dashboard Cite

show abstract

“…It only focuses on the incidence of an event without grading its severity. In addition to the C-PET, International Breast Cancer Study Group (IBCSG)/Linear Analogue Self-Assessment Scales were utilized to address the side effects of hormonal therapy and treatment burden, the results being discussed elsewhere [6]. …”

Section: Methodsmentioning

confidence: 99%

Breast Cancer Patients on Endocrine Therapy Reveal More Symptoms when Self-Reporting than in Pivotal Trials: An Outcome Research Study

Ruhstaller

Moos²,

Rufibach

et al. 2009

Oncology

View full text Add to dashboard Cite

Objectives: The purpose of this investigation was firstly to assess the overall frequency of subjectively experienced symptoms self-reported by patients receiving endocrine therapy and secondly to compare these symptoms with side effects assessed by clinicians in pivotal trials. Methods: Unselected patients with early and advanced breast cancer receiving endocrine therapy were approached consecutively during a routine outpatient visit. They received a questionnaire called Checklist for Patients with Endocrine Therapy (C-PET), a validated self-assessment tool to determine prespecified symptoms associated with endocrine therapy. Data on toxicity were also obtained from previously published trials. Results: 405 patients were approached and 373 agreed to participate in this study. Some symptoms were significantly more often recorded by the women in the adjuvant setting completing the C-PET than by physicians’ reports in pivotal trials: hot flushes/sweats (C-PET 70%, ATAC 40% and BIG1-98 38%), low energy (C-PET 45%, ATAC 15% and BIG1-98 9%), fluid retention (C-PET 22% and BIG1-98 7%) and vaginal dryness (C-PET 30% and BIG1-98 3%). Similar differences were observed in the metastatic and adjuvant setting. Conclusions: A simple tool like the C-PET questionnaire is able to reflect the treatment burden of endocrine therapies and may be helpful to improve communication between patients and care providers. Some symptoms were significantly more often reported by the women in the C-PET than by physicians in pivotal trials.

show abstract

“…Endocrine symptoms may substantially influence the QoL of the patients when they receive adjuvant endocrine treatment for breast cancer. [10] Høybye[11] reported that breast cancer patients ( n = 1051) suffered from cancer- or cancer treatment-related effects. Many of these patients experienced fatigue (66%), lack of concentration (46%), and joint or muscle pains (49%).…”

Section: Resultsmentioning

confidence: 99%

Effectiveness of physical, psychological, social, and spiritual intervention in breast cancer survivors: An integrative review

Liu

Chen

et al. 2016

Asia-Pacific Journal of Oncology Nursing

View full text Add to dashboard Cite

Factors affecting the health outcomes of cancer patients have gained extensive research attention considering the increasing number and prolonged longevity of cancer survivors. Breast cancer survivors experience physical, psychological, social, and spiritual challenges. This systematic literature review aims to present and discuss an overview of main issues concerning breast cancer survivors after treatment. Treatment-related symptoms as well as psychosocial and spiritual aspects of breast cancer survivors are evaluated. Moreover, the benefits of intervention for emotional, physical, social, and spiritual needs of the patient during the survivorship are investigated. This review also proposes avenues for future studies in this field and develops a new, integrated, and complete interpretation of findings on the holistic well-being of women with breast cancer. Thus, this study provides clinicians with a more comprehensive source of information compared with individual studies on symptom experiences.

show abstract

Endocrine symptom assessment in women with breast cancer: what a simple “yes” means

Abstract: Patients' experience of endocrine symptoms needs to be considered both in patient care and research, when interpreting the association between symptoms and QL.

Cited by 11 publications

References 36 publications

Burden of treatment for chronic illness: a concept analysis and review of the literature

Burden of treatment for chronic illness: a concept analysis and review of the literature

Breast Cancer Patients on Endocrine Therapy Reveal More Symptoms when Self-Reporting than in Pivotal Trials: An Outcome Research Study

Effectiveness of physical, psychological, social, and spiritual intervention in breast cancer survivors: An integrative review

Contact Info

Product

Resources

About